Stay updated on Tucatinib in HER2+ Metastatic Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Tucatinib in HER2+ Metastatic Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tucatinib in HER2+ Metastatic Breast Cancer Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The website has been updated from version 2.13.2 to 2.13.3.
    Difference
    0.2%
    Check dated 2024-12-14T22:39:03.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The website has updated the contact details section for the study, now providing information on who to contact for questions about joining the study and where it is taking place, while removing the previous wording about those conducting the study.
    Difference
    7%
    Check dated 2024-12-07T16:12:39.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    33 days ago
    Change Detected
    Summary
    New features have been added to the website, while several options related to data downloads and study details have been removed.
    Difference
    9%
    Check dated 2024-11-23T04:38:17.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    Several key health-related resources, including MedlinePlus and FDA links, have been removed, which may impact access to important genetic and medical information.
    Difference
    1%
    Check dated 2024-11-15T23:49:46.000Z thumbnail image
  7. Check
    48 days ago
    Change Detected
    Summary
    The website has been updated to version 2.12.2, adding several new resources related to genetics, breast cancer, and drug information, while removing the previous version 2.12.1.
    Difference
    12%
    Check dated 2024-11-08T18:25:07.000Z thumbnail image
  8. Check
    55 days ago
    Change Detected
    Summary
    The website has been updated from version 2.12.0 to 2.12.1.
    Difference
    0.2%
    Check dated 2024-11-01T10:47:29.000Z thumbnail image

Stay in the know with updates to Tucatinib in HER2+ Metastatic Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tucatinib in HER2+ Metastatic Breast Cancer Clinical Trial page.